The latest offering of Signify’s diagnostic services adds spirometry testing to detect chronic obstructive pulmonary disease to its previous service line of testing for peripheral arterial disease, colorectal cancer, chronic kidney disease, diabetes and low bone density.
These tests are performed during Signify’s home health evaluation, according to an Oct. 18 Signify news release provided to Becker’s.
“Early diagnosis and management of chronic conditions are critical to achieving better health outcomes and reducing the total cost of care,” Signify Chief Medical Officer Marc Rothman, MD, said. “At Signify, we are performing diagnostic tests in the home to reduce barriers to timely diagnosis and treatment decisions by individuals and their physicians.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
